Total Payments
$1,909
2024 Payments
$323.99
Companies
24
Transactions
105
Medicare Patients
5,454
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$1,756 (92.0%)
Consulting$150.00 (7.9%)
Education$3.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,756 | 101 | 92.0% |
| Consulting Fee | $150.00 | 1 | 7.9% |
| Education | $3.00 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $342.44 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $280.83 | 18 | $0 (2024) |
| United Therapeutics Corporation | $221.73 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $172.22 | 12 | $0 (2023) |
| COMSORT, Inc | $150.00 | 1 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $83.65 | 6 | $0 (2019) |
| Gilead Sciences, Inc. | $80.17 | 5 | $0 (2018) |
| Insmed, Inc. | $71.32 | 3 | $0 (2024) |
| Amgen Inc. | $70.94 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $69.49 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $323.99 | 15 | GlaxoSmithKline, LLC. ($83.66) |
| 2023 | $410.44 | 19 | GlaxoSmithKline, LLC. ($174.69) |
| 2022 | $203.90 | 13 | AstraZeneca Pharmaceuticals LP ($54.31) |
| 2021 | $148.11 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($65.42) |
| 2020 | $12.78 | 1 | AstraZeneca Pharmaceuticals LP ($12.78) |
| 2019 | $147.71 | 9 | Insmed, Inc. ($53.28) |
| 2018 | $314.06 | 12 | COMSORT, Inc ($150.00) |
| 2017 | $347.65 | 25 | United Therapeutics Corporation ($109.53) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.78 | General |
| Category: Immunology | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/06/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: VACCINE | ||||||
| 06/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: RESPIRATORY | ||||||
| 05/16/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Inflammation | ||||||
| 02/13/2024 | United Therapeutics Corporation | ORENITRAM (Drug), REMODULIN | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 01/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: RESPIRATORY | ||||||
| 10/26/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2023 | Inogen, Inc. | INOGEN AT HOME STATIONARY CONCENTRATOR (Device) | Food and Beverage | Cash or cash equivalent | $24.94 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 10/19/2023 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: PULMONOLOGY | ||||||
| 08/25/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: RESPIRATORY | ||||||
| 08/03/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: RESPIRATORY | ||||||
| 07/18/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Respiratory | ||||||
| 07/13/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: IMMUNOLOGY | ||||||
| 06/14/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: RESPIRATORY | ||||||
| 06/13/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,187 | 3,679 | $612,488 | $262,653 |
| 2022 | 17 | 1,387 | 4,400 | $699,082 | $251,948 |
| 2021 | 15 | 1,462 | 5,086 | $783,979 | $324,911 |
| 2020 | 15 | 1,418 | 3,855 | $578,070 | $218,846 |
Total Patients
5,454
Total Services
17,020
Medicare Billing
$1.1M
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 340 | 2,284 | $285,500 | $128,595 | 45.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 97 | 275 | $82,500 | $42,947 | 52.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 245 | 296 | $73,500 | $35,349 | 48.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 269 | $67,250 | $22,917 | 34.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 86 | 242 | $36,300 | $21,487 | 59.2% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 46 | 54 | $38,718 | $3,810 | 9.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $5,750 | $2,346 | 40.8% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2023 | 12 | 14 | $10,360 | $1,428 | 13.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 11 | 11 | $2,200 | $1,015 | 46.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 16 | $2,400 | $865.02 | 36.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 29 | 30 | $2,250 | $669.87 | 29.8% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 54 | 56 | $1,960 | $477.00 | 24.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 52 | 54 | $2,700 | $400.40 | 14.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 53 | 55 | $1,100 | $346.84 | 31.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 366 | 2,799 | $349,875 | $136,424 | 39.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 121 | 330 | $99,000 | $49,577 | 50.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 97 | 296 | $44,400 | $20,944 | 47.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 242 | $60,500 | $20,672 | 34.2% |
| 99224 | Follow-up observation care per day, typically 15 minutes | Facility | 2022 | 196 | 223 | $44,600 | $5,872 | 13.2% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 60 | 66 | $47,322 | $4,418 | 9.3% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 58 | 63 | $14,175 | $2,865 | 20.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $5,500 | $2,420 | 44.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $3,500 | $1,941 | 55.5% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2022 | 11 | 15 | $11,100 | $1,559 | 14.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 24 | $3,600 | $1,220 | 33.9% |
About Dr. Mhd Chaker, MD
Dr. Mhd Chaker, MD is a Pulmonary Disease healthcare provider based in Shelbyville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467432682.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mhd Chaker, MD has received a total of $1,909 in payments from pharmaceutical and medical device companies, with $323.99 received in 2024. These payments were reported across 105 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,756).
As a Medicare-enrolled provider, Chaker has provided services to 5,454 Medicare beneficiaries, totaling 17,020 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Shelbyville, KY
- Active Since 01/23/2006
- Last Updated 10/01/2024
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1467432682
Products in Payments
- TRELEGY ELLIPTA (Drug) $189.44
- ORENITRAM (Drug) $186.43
- OFEV (Drug) $151.41
- ZERBAXA (Drug) $150.00
- DUPIXENT (Biological) $102.27
- STIOLTO RESPIMAT (Drug) $94.52
- AREXVY (Drug) $87.12
- TEZSPIRE (Biological) $84.65
- Arikayce (Drug) $71.32
- LONHALA MAGNAIR (Drug) $62.57
- FASENRA (Biological) $42.96
- BREZTRI (Drug) $41.20
- Yupelri (Drug) $37.66
- NUCALA (Biological) $36.94
- BEVESPI AEROSPHERE (Drug) $36.55
- CHARTIS CATHETER (Device) $35.61
- STIOLTO (Drug) $34.90
- ELIQUIS (Drug) $26.81
- OPSUMIT MACITENTAN (Drug) $26.55
- INOGEN AT HOME STATIONARY CONCENTRATOR (Device) $24.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.